Endoglin (CD105) expression in angiogenesis of colon cancer: Analysis using tissue microarrays and comparison with other endothelial markers

Virchows Archiv

Volumn 448, Issue 2, 2006, Pages 127-134

  Minhajat, Rahmawati ^a   Mori, Daisuke ^a   Yamasaki, Fumio ^a   Sugita, Yasuo ^a   Satoh, Toshimi ^a   Tokunaga, Osamu ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; CD105; Colon tumor; Endothelial markers; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURGERY; CAPILLARY ENDOTHELIUM; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; TISSUE FIXATION; TISSUE MICROARRAY; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD31; COLONIC NEOPLASMS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 32544436577     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0062-8     Document Type: Article

References (30)

1. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T (2002) Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131:S109-S113
2. Becker CM, Farnebo FA, Iordanescu I, Behonick DJ, Shih MC, Dunning P, Christofferson R, Mulligan RC, Taylor GA, Kuo CJ, Zetter BR (2002) Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1. Cancer Biol Ther 1:548-553
3. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, Thorpe PE (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1:1623-1634
4. Cheryl AB, Jennifer JS, Miao J, Jill MJ, Jordan LM, Mary EM (2000) Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 96:224-228
5. Dales JP, Garcia S, Carpentier S, Andrac L, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C (2004) Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression. Hum Pathol 35:176-183
6. Faviana P, Boldrini L, Spisni R, Fontanini G et al (2002) Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression. Oncol Rep 9:617-620
7. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM (2004) Ultra-structural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem 52:87-101
8. Fonsatti E, Sigalotti L, Arslan P, Altomonte M, Maio M (2003) Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets 3:427-432
9. Fonsatti E, Altomonte M, Arslan P, Maio M (2003) Endoglin (CD105): a target for anti-angiogenetic cancer therapy. Curr Drug Targets 4:291-296
10. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557-6563
11. Greenaway J, Connor K, Pederson HG, Coomber BL, LaMarre J, Petrik J (2004) VEGF and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145:2896-2905
12. Jourdan F, Sebbagh N, Comperat E, Flejou JF (2003) Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443:115-121
13. Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255-1257
14. Kawaguchi T, Yamamoto S, Kudoh S, Goto K, Wakasa K, Sakurai M (1997) Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma. Anticancer Res 17:3743-3746
15. Kumar P, Wang JM, Bernabeu C (1996) CD105 and angiogenesis. J. Pathol 178:363-366
16. Li C, Gardy R, Seon BK, Duff SE, Abdalla S, Ranehan A, O'Dwyer ST, Haboubi N, Kumar S (2003) Both high intra-tumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 88:1424-1431
17. Li C, Guo B, Bernabeu C, Kumar C (2001) Angiogenesis in breast cancer: the role of transforming growth factor and CD105. Microsc Res Tech 4:437-449
18. Nasi A, Boulware D, Kaiser HE, Coppola D (2004) Flat and polyploid adenocarcinomas of the colorectum: a comparative histomorphologic analysis of 47 cases. Hum Pathol 35:604-611
19. Nicholl ID, Dunlop MG (1999) Molecular markers of prognosis in colorectal cancer. J Natl Cancer Inst 91:1267-1269
20. Okada K, Satoh T, Fujimoto K, Tokunaga O (2004) Interaction between morphology and angiogenesis in human early colorectal cancers. Pathol Int 54:490-497
21. Price EA, Coombe DR, Murray JC (1998) Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int J Cancer 65:513-518
22. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984-992
23. Siemann DW, Chaplin DJ, Horsman MR (2004) Vascular-targeting therapies for treatment of malignant disease. Cancer 100:2491-2499 [review]
24. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968
25. Volgestein B, Fearon ER, Hamilton SR (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
26. Von Marschall Z, Cramer T, Hocker M, Burde R, Rosewicz S (2000) De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology 119:1358-1372
27. Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J, Hunter RD (1993) A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 54:363-370
28. Wilkstrom P, Lissbrant IF, Stattin P, Egevad L, Bergh A (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51:268-275
29. Yasutomi M (ed) (1999) Japanese classification of colorectal carcinoma. Kanehara, Tokyo
30. Yu JX, Zhang XT, Liao YQ, Zhang QY, Chen H, Lin M, Kumar S (2003) Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. World J Gastroenterol 9:2866-2869